Senores Pharmaceuticals Limited has informed the Exchange regarding giving corporate guarantee for credit facilities availed by Apnar Pharma Private Limited, Subsidiary of the Company from ....

Date: August 24, 2026 To, To, Sr. General Manager Sr. General Manager Listing Department Listing Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street Bandra Kurla Complex Mumbai – 400001 Bandra (E), Mumbai – 400 051 BSE Scrip Code: 544319 NSE Symbol: SENORES Dear Sir/Madam, Subject: Intimation for giving corporate guarantee for credit facilities availed by Apnar Pharma Private Limited, Subsidiary of the Company from ICICI Bank Limited Pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended from time to time, we would like to inform you that the Company has issued Corporate Guarantee for the credit facility availed by Apnar Pharma Private Limited, Subsidiary of the Company, from ICICI Bank Limited for an amount of INR. 62 Crores. Details as required to be furnished under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 is enclosed herewith as Annexure I. You are requested to take the same on record. Thanking you. For Senores Pharmaceuticals Limited Deval Rajnikant Shah Whole-Time Director & CFO DIN: 00332722 Encl: As above Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263 Annexure I Details as required under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sr. No. Particulars Details 1. Name of party for which such guarantee Apnar Pharma Private Limited –Subsidiary of or indemnity or surety was given the Company (“APNAR”). 2. Whether the promoter/ promoter group/ The promoter and promoter group have group companies have any interest in this interest to the extent of their directorship in transaction? If yes, nature of interest and APNAR. details thereof and whether the same is done at “arm’s length” The corporate guarantee extended is at arm’s length. 3. Brief details of such guarantee or The Corporate Guarantee of INR 62 Crores is indemnity or becoming a surety viz. brief given by the Company on August 24, 2026, in details of agreement entered (if any) favor of ICICI Bank Ltd. (“Bank”) to secure including significant terms and credit facilities sanctioned to APNAR. The conditions, including amount of Corporate Guarantee is valid till the closure of guarantee the credit facilities. 4. Impact of such guarantee or indemnity or At this point, there is no impact of this surety on listed entity guarantee on the Company other than disclosure in the financial statements as a Contingent Liability. Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263